The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Mead Johnson Nutrition Co

NYSE: MJN
Last

(U.S.) $87.86

Today's change+0.01 +0.01%
Updated February 28 12:43 PM EST. Delayed by at least 15 minutes.
 

Mead Johnson Nutrition Co

NYSE: MJN
Last

(U.S.) $87.86

Today's change+0.01 +0.01%
Updated February 28 12:43 PM EST. Delayed by at least 15 minutes.

Mead Johnson Nutrition Co up slightly

Mead Johnson Nutrition Co is up just (U.S.)$0.01 today to (U.S.)$87.86. Over the last five days, shares have gained 0.45% and 24.17% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $87.81
  • Previous close(U.S.) $87.85
  • High(U.S.) $87.97
  • Low(U.S.) $87.77
  • Bid / Ask(U.S.) $87.86 / (U.S.) $87.87
  • YTD % change+24.17%
  • Volume966,273
  • Average volume (10-day)5,294,519
  • Average volume (1-month)5,961,240
  • Average volume (3-month)3,243,504
  • 52-week range(U.S.) $69.25 to (U.S.) $94.40
  • Beta1.50
  • Trailing P/E30.05×
  • P/E 1 year forward27.23×
  • Forward PEG12.13×
  • Indicated annual dividend(U.S.) $1.65
  • Dividend yield1.88%
  • Trailing EPS(U.S.) $2.92
Updated February 28 12:43 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.68%

Based on its net profit margin of 14.68%, Mead Johnson Nutrition Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.17%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue938942962967
Total other revenue--------
Total revenue938942962967
Gross profit604608615608
Total cost of revenue334333348359
Total operating expense709727812771
Selling / general / administrative352373351362
Research & development23262529
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)615523
Other operating expenses, total------0
Operating income228214150196
Interest income (expense), net non-operating-30-30-29-25
Gain (loss) on sale of assets--------
Other--------
Income before tax202188124173
Income after tax14915677131
Income tax, total53324742
Net income14915573128
Total adjustments to net income-1-100
Net income before extra. items14915573128
Minority interest1-1-4-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14915572128
Inc. avail. to common incl. extra. items14915572128
Diluted net income14915572128
Dilution adjustment--------
Diluted weighted average shares185187187190
Diluted EPS excluding extraordinary itemsvalue per share0.800.830.390.67
Dividends per sharevalue per share0.410.410.410.41
Diluted normalized EPSvalue per share0.900.870.751.01